Zaloguj się

Gotowe bibliografie tematyczne / Human ovarian carcinoma cells / Książki

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Human ovarian carcinoma cells.

Książki na temat „Human ovarian carcinoma cells”

Autor: Grafiati

Data publikacji: 2 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 16 najlepszych książek naukowych na temat „Human ovarian carcinoma cells”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Byrne, Karen. Targeting of radiolabelled antibodies to ovarian carcinoma cells and spheroids. University of Manchester, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Weinstein, Ellen Michele. Inhibition of CA 125, a novel high molecular weight glycoprotein expressed by an ovarian carcinoma cell line: 0VCA 433, is related to glucocorticoid effects of altered cell growth, morphology, and growth pattern. s.n.], 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Linda, Giudice, Santa Eileen, Pool Robert, Institute of Medicine (U.S.). Board on Health Sciences Policy, and National Research Council (U.S.). Board on Life Sciences., eds. Assessing the medical risks of human oocyte donation for stem cell research: Workshop report. National Academies Press, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

K, Woodruff Teresa, and Snyder Karrie Ann, eds. Oncofertility: Fertility preservation for cancer survivors. Springer Verlag, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

1963-, Woodruff Teresa K., and Snyder Karrie Ann, eds. Oncofertility: Fertility preservation for cancer survivors. Springer, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Hayat, M. A. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas: Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma. Elsevier Science & Technology Books, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Sheldon, Katherine Mary. Characterization of immunoconjugates active against human carcinoma cells "in vitro". 1987.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Josephs, Debra H., Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis. Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0001.

Pełny tekst źródła

Streszczenie:

Despite improvements over the past decade in the treatment of ovarian cancer, many patients are at risk of recurrent disease and emerging drug resistance. The increased selectivity and reduced toxicity of molecularly targeted anti-cancer agents renders them attractive for development in ovarian cancer, and monoclonal antibodies targeting ovarian cancer-specific tumor antigens represent the largest such group investigated in this clinical setting. This chapter describes examples of monoclonal antibodies clinically evaluated for efficacy in ovarian cancer. These agents recognize molecular target

Style APA, Harvard, Vancouver, ISO itp.

9

Jakobson, Eva. Studies on positive and negative growth regulation in human bladder carcinoma cells. 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Hayat, M. A. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 4: Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma ... in Situ Hybridization of Human Carcinomas). Academic Press, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Hayat, M. A. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 4: Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma ... in Situ Hybridization of Human Carcinomas). Academic Press, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Farghaly, Samir A., ed. Ovarian Cancer Immunotherapy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.001.0001.

Pełny tekst źródła

Streszczenie:

Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecul

Style APA, Harvard, Vancouver, ISO itp.

13

Jong, Steven de. Cell biological aspects of drug-resistance in human small cell lung carcinoma cells. 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Zhang, Zhifen. Detection of M-CSF and its receptor in huma follicular granulosa cells: Expression patterns of M-CSF in human ovarian follicular fluid and serum. 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Farghaly, Samir A. Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0005.

Pełny tekst źródła

Streszczenie:

The standard management for epithelial ovarian cancer (EOC) is a combination of aggressive debulking surgery with residual tumor of less than 1 cm and platinum-based chemotherapy. However, a high percentage of patients experience disease recurrence. Extensive efforts to find new therapeutic options have been made, albeit cancer cells develop drug resistance and malignant progression occurs. Novel therapeutic strategies are needed to enhance progression-free survival and overall survival of patients with advanced EOC. Several preclinical and clinical studies investigated feasibility and efficac

Style APA, Harvard, Vancouver, ISO itp.

16

Lee, Gregory. Epitope/Peptide-Based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0007.

Pełny tekst źródła

Streszczenie:

Two monoclonal antibodies, RP215 and GHR106, were selected, respectively, for the research and development of anti-cancer drugs targeting ovarian cancer and other types of human cancer. RP215 was shown to react with a carbohydrate-associated epitope located mainly in the variable regions of immunoglobulin heavy chains expressed on the surface of almost all cancer cells in humans. GHR106 was generated against a synthetic peptide corresponding to N1-29 amino acid residues in the extracellular domains of human GnRH receptor, which is surface-expressed by most cancer cells as well as the anterior

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!